These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 9321739

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
    Rahbari-Oskoui F, Williams O, Chapman A.
    Nephrol Dial Transplant; 2014 Dec; 29(12):2194-201. PubMed ID: 24463189
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autosomal-dominant polycystic kidney disease and hypertension: a review.
    Florijn KW, van Saase JL, Breuning MH, Chang PC.
    Contrib Nephrol; 1992 Dec; 97():71-92. PubMed ID: 1386018
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB, Johnson A, Gabow PA, Schrier RW.
    N Engl J Med; 1990 Oct 18; 323(16):1091-6. PubMed ID: 2215576
    [Abstract] [Full Text] [Related]

  • 13. Renin-Angiotensin-aldosterone system in autosomal dominant polycystic kidney disease.
    Tkachenko O, Helal I, Shchekochikhin D, Schrier RW.
    Curr Hypertens Rev; 2013 Feb 18; 9(1):12-20. PubMed ID: 23971639
    [Abstract] [Full Text] [Related]

  • 14. Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB, Schrier RW.
    Semin Nephrol; 1991 Nov 18; 11(6):653-60. PubMed ID: 1767138
    [Abstract] [Full Text] [Related]

  • 15. ACE inhibitors, left ventricular mass and renal cyst growth in ADPKD.
    Schrier RW.
    Pharmacol Res; 2016 Dec 18; 114():166-168. PubMed ID: 27794499
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
    Loghman-Adham M, Soto CE, Inagami T, Cassis L.
    Am J Physiol Renal Physiol; 2004 Oct 18; 287(4):F775-88. PubMed ID: 15187005
    [Abstract] [Full Text] [Related]

  • 18. A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.
    Kocyigit I, Yilmaz MI, Unal A, Ozturk F, Eroglu E, Yazici C, Orscelik O, Sipahioglu MH, Tokgoz B, Oymak O.
    Am J Nephrol; 2013 Oct 18; 38(3):218-25. PubMed ID: 23988725
    [Abstract] [Full Text] [Related]

  • 19. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
    Ramanathan G, Elumalai R, Periyasamy S, Lakkakula B.
    Iran J Kidney Dis; 2014 Jul 18; 8(4):265-77. PubMed ID: 25001132
    [Abstract] [Full Text] [Related]

  • 20. Renin-Angiotensin-Aldosterone System Antagonism and Polycystic Kidney Disease Progression.
    Hian CK, Lee CL, Thomas W.
    Nephron; 2016 Jul 18; 134(2):59-63. PubMed ID: 27476173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.